Formulation science
preformulation, dosage-form design, excipient function, physicochemical characterisation, stability, optimisation, scale-up and quality-by-design.
Aims & scope
JPBS publishes pharmaceutical research that links formulation and drug delivery to biological, therapeutic or clinical performance.
A clear fit
Research belongs here when pharmaceutical design changes the outcome.
The Journal of Pharmaceutical and Biomedical Sciences is dedicated to advancing pharmaceutical science through the development, characterisation and evaluation of pharmaceutical formulations and drug-delivery systems with demonstrable biological, therapeutic or clinical relevance.
The journal focuses on the relationship between pharmaceutical design and therapeutic performance, with particular emphasis on how formulation strategies, pharmaceutical technologies and drug-delivery approaches can improve drug stability, solubility, bioavailability, targeting, efficacy, safety and clinical applicability.
A central objective is to promote research that goes beyond formulation development alone and demonstrates how pharmaceutical interventions influence biological function or therapeutic outcomes. Studies are especially encouraged when they clearly link formulation or pharmaceutical technology to biological performance and therapeutic benefit.
Scope
JPBS publishes rigorous pharmaceutical-science research in which formulation, drug-delivery design or pharmaceutical technology is central to the study and demonstrably relevant to biological, therapeutic or clinical performance.
Interdisciplinary studies are welcome when they directly advance the development, evaluation or application of a pharmaceutical product or delivery system. Biomedical, clinical, molecular and materials-based research is considered when the pharmaceutical contribution remains clear and substantive.
Drug delivery
modified-release, targeted, transdermal, topical, oral, mucosal, injectable and implantable delivery systems.
Advanced platforms
nanoparticles, liposomes, lipid-based carriers, polymeric systems, micelles, nanostructures, hydrogels and related delivery technologies.
Biopharmaceutics and pharmacokinetics
absorption, distribution, transport, release, permeability, bioavailability, bioequivalence and exposure–response relationships.
Pharmaceutical technology
manufacturing, processing, product characterisation, formulation optimisation and stability-indicating development.
Therapeutic performance
formulation-to-outcome studies addressing biological activity, efficacy, safety, tolerability or therapeutic index.
Biomaterials and functional materials
pharmaceutical uses of biomaterials and nanomaterials developed for formulation, delivery or therapeutic application.
Natural products
formulation, standardisation, delivery, stability, bioavailability enhancement and therapeutic evaluation of plant-derived bioactives.
Biologics and biotechnology
formulation and delivery of peptides, proteins, vaccines and other biotechnology-derived therapeutic agents.
Antimicrobial therapy
pharmaceutical strategies that improve delivery, efficacy or use of antimicrobial agents.
Analysis and characterisation
analytical and bioanalytical work directly supporting formulation, delivery, release, stability, bioavailability or pharmacokinetics.
Computational pharmaceutics
modelling and predictive work directly connected to formulation or delivery and, where appropriate, experimentally validated.
Translational pharmaceutics
studies that progress from pharmaceutical design to biological, preclinical or clinical outcomes.
What the journal prioritises
The journal prioritises studies that demonstrate a clear relationship between pharmaceutical design, formulation or delivery, biological performance, and therapeutic or clinical relevance.
The Journal of Pharmaceutical and Biomedical Sciences seeks to provide a focused platform for pharmaceutical research that demonstrates not only how a pharmaceutical system is developed but also why its design matters for biological and therapeutic performance.
Out of scope
Research that is purely biomedical, clinical, microbiological, molecular or materials-science oriented, without a substantive pharmaceutical component, falls outside the journal’s primary scope.
The journal does not consider work whose primary purpose is marketing a product, or manuscripts that withhold the method needed to test the claim.